Tag: pharmaceutical patents
Patent Exclusivity vs Market Exclusivity: What’s the Real Difference for Drug Prices?
Patent exclusivity and market exclusivity are two different legal tools that protect new drugs. One comes from the patent office, the other from the FDA. Understanding the difference explains why drug prices stay high-and who controls when generics arrive.
read morerecent posts
Two congressional bills aim to fix drug and healthcare provider shortages in 2026, but both are stalled by the longest government shutdown in U.S. history. Here's what they do, why they're stuck, and who's paying the price.
Published ON: 16 JanTriple inhaler therapy combines three medications to reduce COPD exacerbations in high-risk patients with elevated eosinophil counts. Learn who benefits, the risks, and how adherence impacts outcomes.
Published ON: 11 JanLearn what lab tests are actually needed when taking statins, when to worry about liver or muscle side effects, and why routine testing may do more harm than good. Evidence-based guidance for safe, effective use.
Published ON: 1 JanOpioids in older adults increase fall risk, trigger delirium, and can be deadly at standard doses. Learn why lower doses, careful monitoring, and non-drug options are critical for safe pain management in seniors.
Published ON: 4 JanCulture shapes how people accept even the most generic products - from medicines to apps. Understanding cultural dimensions like uncertainty avoidance and collectivism can double adoption rates and build real trust.
Published ON: 3 Jan